Glycomine

Investment area
Novo Ventures
Region
Western USA
Date of investment
July 2019

Glycomine focuses on genetic disorders of protein and lipid glycosylation, which often cause severe debilitation in patients. There are 100 known glycosylation disorders. Glycomine is currently addressing two disorders of glycosylation: PMM2-CDG and Ngly1 deficiency.

Glycomine

Investment area
Novo Ventures
Region
Western USA
Date of investment
July 2019

Glycomine focuses on genetic disorders of protein and lipid glycosylation, which often cause severe debilitation in patients. There are 100 known glycosylation disorders. Glycomine is currently addressing two disorders of glycosylation: PMM2-CDG and Ngly1 deficiency.

Glycomine

Investment area
Novo Ventures
Region
Western USA
Date of investment
July 2019

Glycomine focuses on genetic disorders of protein and lipid glycosylation, which often cause severe debilitation in patients. There are 100 known glycosylation disorders. Glycomine is currently addressing two disorders of glycosylation: PMM2-CDG and Ngly1 deficiency.